Swedish Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Swedish Medical Center sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).

30 total trials 4 currently recruiting 20 completed early-phase tilt top decile by trial count

Swedish Medical Center: 30 sponsored US clinical trials, 4 recruiting.

Swedish Medical Center sponsors 30 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 20 completed. 1 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Esophageal Reflux, with 1 trials.

Top-decile sponsor footprint

Swedish Medical Center ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 32/100

20 of 26 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

30 total, page 1 of 1

RECRUITING NA

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

NCT07108660

RECRUITING Early Phase 1

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

NCT05380349

RECRUITING NA

Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial

NCT06411431

RECRUITING Phase 1

Minimally Invasive Esophagectomy Pain Control Trial

NCT05906134

TERMINATED Phase 2

Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy

NCT04542993

COMPLETED Phase 4

Management of Pleural Space Infections

NCT03873766

TERMINATED NA

A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy

NCT03570996

COMPLETED Phase 1

Cancer Stem Cell High-Throughput Drug Screening Study

NCT02654964

COMPLETED NA

Staple vs. Suture in Robotic Prostatectomy

NCT03480074

COMPLETED

Study of Human Sensory Perception

NCT01613911

COMPLETED NA

Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery

NCT01562106

COMPLETED

Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient

NCT01513213

TERMINATED NA

Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques

NCT01422473

COMPLETED Phase 1

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

NCT01294826

COMPLETED NA

Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer

NCT01241721

COMPLETED

Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP)

NCT01257880

TERMINATED Early Phase 1

Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer

NCT01292733

COMPLETED NA

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment

NCT00714480

COMPLETED Phase 2

Phase II Trial of LBH589 in Refractory Colorectal Cancer

NCT00690677

TERMINATED Phase 2

A Study of a Melatonin Receptor Agonist to Prevent Migraine

NCT00739024

COMPLETED Phase 2

Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

NCT00456716

COMPLETED Phase 2

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

NCT00430261

COMPLETED Phase 1

Rituxan With or Without Methotrexate in Psoriatic Arthritis

NCT00509678

COMPLETED Phase 2

Nursing Home Pain Management Algorithm Clinical Trial

NCT01399567

COMPLETED NA

Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation

NCT00364650

COMPLETED Phase 2

Phase II Trial of RAD001 in Refractory Colorectal Cancer

NCT00337545

COMPLETED Phase 1

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

NCT00316407

TERMINATED Phase 2

Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer

NCT00316433

COMPLETED Phase 1

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

NCT00316420

COMPLETED NA

Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures

NCT01260935

What is open in the Swedish Medical Center pipeline

4 recruiting of 30 indexed (13% open); 20 completed (67%).

Phase mix: 1 late (III/IV) vs 16 early (I/II) (early-phase heavy).

Top condition: Esophageal Reflux (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Swedish Medical Center: open-pipeline peers nationwide

Peers matched on 30 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

Swedish Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 101520253035 0%5%10%15%20% Total trials Recruiting share Swedish Medical CenterBiotronikCharles Drew University of Medicine and ScienceChiesi Farmaceutici S.p.A.Debiopharm InternationalDizal PharmaceuticalsEdgewise TherapeuticsEpicentRxEuropean Organisation for Research and Treatment of Cancer - EORTC
Swedish Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Swedish Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 30 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this Swedish Medical Center page

30 registered trials is a research-attention snapshot, not an endorsement of Swedish Medical Center or any single study.

  • 4 of Swedish Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Esophageal Reflux is the condition Swedish Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Esophageal Reflux trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Swedish Medical Center pipeline card: 30 registered trials from official public datasets.Report a data error.